One comment

  1. Hi,

    small nucleotide sequences have been identified having the capacity to lock and unlock genes in controlled/uncontrolled ways. Is there any chance that miRNAs can be used as a therapeutic tool for COVID-19 such as in the control of lympho-proliferation, apaptosis as well as bioavailability enhancers since RNA based vaccines are being used for COVID-19 and a good level of efficacy has been reported in several settings. Additionally, with shorter of teleomere being associated to disease severity in COVID-19, can chromosome maintenance (such as Tyrosine kinase inhibitors) be a good treatment option although I am aware of the ethical issues related to nucleic acid based treatments. My current understanding of COVID-19 identifies alot with cancer and I believe that with some tweaking around, cancer therapies can be applicable to it, more of the ”old drugs, new disease” approach.

    Thank you

Leave a Reply

Your email address will not be published. Required fields are marked *


Time limit is exhausted. Please reload CAPTCHA.